Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,240.00
Bid: 2,236.00
Ask: 2,244.00
Change: 14.00 (0.63%)
Spread: 8.00 (0.358%)
Open: 2,222.00
High: 2,242.00
Low: 2,200.00
Prev. Close: 2,226.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible bond offering

17 May 2011 15:45

RNS Number : 7733G
Derwent London PLC
17 May 2011
 



17 May 2011

 

NOT FOR DISTRIBUTION IN OR TO THE U.S., CANADA, AUSTRALIA OR JAPAN, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW

 

Derwent London plc Convertible Bond Offering

 

Derwent London plc (the "Group", the "Company" or "Derwent London") announces the final terms of its offering of £175 million of Convertible Bonds due 2016 (the "Bonds"), announced earlier today.

 

The Bonds will have a coupon of 2.75% per annum payable semi-annually in arrear and will be convertible into fully paid Ordinary Shares of the Company ("the Shares"). The initial conversion price has been set at £22.22, a premium of 30% above the volume weighted average price of the Shares from launch to pricing less the £0.2025 to be paid to shareholders on the share register on 20 May 2011.

 

Settlement is expected to take place on or about 2 June 2011 (the "Settlement Date").

 

John Burns, Chief Executive Officer of Derwent London said:

 

"We are very pleased with the result of this bond offer and the confidence that the market has shown in the future prospects of the Group. The bonds have been priced at the top end of the premium range and the transaction was substantially oversubscribed at that level."

 

J.P. Morgan Cazenove and RBS Hoare Govett Limited are acting as Joint Global Coordinators and Joint Bookrunners and HSBC Bank plc and UBS Limited are acting as Joint Bookrunners for the offering.

 

For further information, please contact:

Derwent London John Burns, Chief Executive Officer

Tel: +44 (0)20 7659 3000 Damian Wisniewski, Finance Director

 

About Derwent London plc

Derwent London plc is the largest central London focused REIT with an investment portfolio of £2.4bn as at 31 December 2010. The Group is one of London's most innovative office specialist property regenerators and investors and is well known for its established design-led philosophy and creative management approach to development.

 

Derwent London's core strategy is to acquire and own a portfolio of central London property that has reversionary rents and significant opportunities to enhance and extract value through refurbishment, regeneration and redevelopment. The Group owns and manages an investment portfolio of 5.4 million sqft (500,000m2), as at 31 December 2010, of which 95% is located in central London, with a specific focus on the West End and the areas bordering the City of London. Landmark schemes by Derwent London include Angel Building EC1, Arup Phases II & III W1, Qube W1, Horseferry House SW1, Johnson Building EC1, Davidson Building WC2 and Tea Building E1.

 

Derwent London came first in the property sector in the 2010 awards for 'Britain's Most Admired Companies'.

 

DISCLAIMER

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities in the United States or in any other jurisdiction. This announcement is not for distribution, directly or indirectly in or into the United States (as defined in Regulation S under the US Securities Act of 1933, as amended (the "Securities Act")). The securities referred to herein have not been and will not be registered under the Securities Act and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

 

This communication is directed only at persons who (i) are outside the United Kingdom or (ii) have professional experience in matters relating to investments falling within Article 19(5) of The Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) are persons falling within Article 49 2(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). This communication must not be read, acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons.

 

The Joint Bookrunners are acting on behalf of the issuer and the Company and no one else in connection with the Bonds and will not be responsible to any other person for providing the protections afforded to clients of the Joint Bookrunners or for providing advice in relation to the Bonds.

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Joint Bookrunners or by any of their respective officers, employees or agents as to or in relation to the accuracy or completeness of this any written or oral information made available to any interested party or its advisers and any liability therefor is hereby expressly disclaimed.

Stabilisation/FSA.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CONSFEFLWFFSELI
Date   Source Headline
23rd Apr 20199:00 amRNSBondholders' meeting
15th Apr 20191:00 pmRNSAnnual Report & Accounts 2018 and Notice of AGM
5th Apr 20194:30 pmRNSDirector/PDMR Shareholding
29th Mar 20193:00 pmRNSDirector Declaration
29th Mar 201911:00 amRNSTotal Voting Rights
28th Mar 20197:00 amRNSBrunel Building Office Space Fully Pre-Let
21st Mar 201911:00 amRNSDirector/PDMR Shareholding
20th Mar 20191:30 pmRNSBlock listing Interim Review
15th Mar 20193:00 pmRNSHolding(s) in Company
13th Mar 201910:30 amRNSDirector/PDMR Shareholding
12th Mar 201910:00 amRNSDirector/PDMR Shareholding
5th Mar 201910:30 amRNSAdditional Listing
28th Feb 20195:00 pmRNSTotal Voting Rights
27th Feb 20199:30 amRNSHolding(s) in Company
26th Feb 20195:00 pmRNSDividend Declaration
26th Feb 20197:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
18th Feb 20199:00 amRNSHolding(s) in Company
31st Jan 20194:30 pmRNSTotal Voting Rights
28th Dec 20183:00 pmRNSTotal Voting Rights
13th Dec 20185:00 pmRNSHolding(s) in Company
30th Nov 20181:00 pmRNSTotal Voting Rights
30th Nov 201810:00 amRNSInvestor and Analyst Presentation and Tour
23rd Nov 20187:00 amRNSDirectorate Change
22nd Nov 20187:00 amRNS£250 Million US Private Placement
8th Nov 20187:00 amRNSQ3 2018 Business Update
7th Nov 20183:00 pmRNSHolding(s) in Company
31st Oct 20183:00 pmRNSTotal Voting Rights
17th Oct 201811:00 amRNSAdditional Listing
8th Oct 20189:43 amRNSChange of Credit Rating Agency
4th Oct 20184:00 pmRNSHolding(s) in Company
28th Sep 201811:00 amRNSTotal Voting Rights
20th Sep 20183:00 pmRNSBlock listing Interim Review
12th Sep 20185:30 pmRNSDirector/PDMR Shareholding
31st Aug 20181:00 pmRNSTotal Voting Rights
30th Aug 201811:00 amRNSAdditional Listing
28th Aug 20184:00 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSDirectorate Change
9th Aug 20187:00 amRNSHalf-year Results
31st Jul 201811:00 amRNSTotal Voting Rights
30th Jul 201810:00 amRNSHolding(s) in Company
4th Jul 201810:00 amRNSAdditional Listing
2nd Jul 201812:00 pmRNSHolding(s) in Company
29th Jun 20185:00 pmRNSDirector/PDMR Shareholding
29th Jun 20184:30 pmRNSTotal Voting Rights
14th Jun 20183:55 pmRNSSony Pictures Take Leading Role At Brunel Building
31st May 20181:00 pmRNSTotal Voting Rights
25th May 20183:00 pmRNSBlock listing Interim Review
18th May 201812:15 pmRNSResults of 2018 Annual General Meeting
16th May 201811:00 amRNSAdditional Listing
15th May 20185:30 pmRNSBondholders' meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.